back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-09-02 18:13 Tx date 2025-09-01 |
$ONC
Oncolytics Biotech Inc. |
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-50,000 vol |
338,183 | |
| Filed 2025-08-22 18:50 Tx date 2025-08-22 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-70,000 vol |
1,389,200 | |
| Filed 2025-08-22 18:49 Tx date 2025-08-18 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$615,600
+570,000 vol $1.08 each |
1,459,200 | |
| Filed 2025-08-22 18:45 Tx date 2025-08-18 |
$ONC
Oncolytics Biotech Inc. |
Aromando, Andrew P.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$324,000
+300,000 vol $1.08 each |
1,050,000 | |
| Filed 2025-08-22 18:42 Tx date 2025-08-18 |
$ONC
Oncolytics Biotech Inc. |
Kelly, Jared Ryan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$486,000
+450,000 vol $1.08 each |
5,200,000 | |
| Filed 2025-08-22 18:39 Tx date 2025-08-18 |
$ONC
Oncolytics Biotech Inc. |
Pisano, Wayne
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$170,100
+157,500 vol $1.08 each |
307,500 | |
| Filed 2025-08-22 18:37 Tx date 2025-08-18 |
$ONC
Oncolytics Biotech Inc. |
Andrews, Patricia
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$162,000
+150,000 vol $1.08 each |
195,000 | |
| Filed 2025-08-22 18:34 Tx date 2025-08-18 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$615,600
+570,000 vol $1.08 each |
1,520,720 | |
| Filed 2025-08-22 18:31 Tx date 2025-08-18 |
$ONC
Oncolytics Biotech Inc. |
Rigby, Jonathan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$162,000
+150,000 vol $1.08 each |
255,000 | |
| Filed 2025-08-22 18:29 Tx date 2025-08-18 |
$ONC
Oncolytics Biotech Inc. |
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$162,000
+150,000 vol $1.08 each |
255,000 | |
| Filed 2025-08-22 18:26 Tx date 2025-08-18 |
$ONC
Oncolytics Biotech Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$162,000
+150,000 vol $1.08 each |
275,263 | |
| Filed 2025-08-22 18:24 Tx date 2025-08-18 |
$ONC
Oncolytics Biotech Inc. |
Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$162,000
+150,000 vol $1.08 each |
270,000 | |
| Filed 2025-08-22 18:20 Tx date 2025-08-18 |
$ONC
Oncolytics Biotech Inc. |
Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$162,000
+150,000 vol $1.08 each |
270,000 | |
| Filed 2025-08-22 18:16 Tx date 2025-08-18 |
$ONC
Oncolytics Biotech Inc. |
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$163,061
+150,983 vol $1.08 each |
388,183 | |
| Filed 2025-08-22 18:13 Tx date 2025-08-18 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$259,200
+240,000 vol $1.08 each |
603,257 | |
| Filed 2025-08-18 19:00 Tx date 2025-08-18 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,967 vol |
69,842 | |
| Filed 2025-08-18 18:57 Tx date 2025-08-18 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-1,967 vol |
35,217 | |
| Filed 2025-08-18 18:54 Tx date 2025-08-18 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+7,967 vol |
156,069 | |
| Filed 2025-08-18 18:53 Tx date 2025-08-18 |
$ONC
Oncolytics Biotech Inc. |
Heineman, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-7,967 vol |
114,617 | |
| Filed 2025-08-18 18:50 Tx date 2025-08-18 |
$ONC
Oncolytics Biotech Inc. |
Levin, Amy
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$3,869,089
+1,967 vol $1,967 each |
38,253 |